Claudia Mattern
21Patents
8h-index
9Co-inventors
68Inventor score
Filing activity: Jun 17, 1994 → Jan 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8784882B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 67 | Active |
| US5756071A | Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier | Human Necessities | 43 | Expired |
| US8574622B2 | Controlled release delivery system for nasal applications | Human Necessities | 14 | Active |
| US8877230B2 | Controlled release delivery system for nasal applications | Human Necessities | 14 | Active |
| US8784869B2 | Controlled release delivery system for nasal applications and methods of treatment | Human Necessities | 13 | Active |
| US8609043B2 | Use of a container of an inorganic additive containing plastic material | Human Necessities | 10 | Active |
| US5578588A | Medicament for increasing the testosterone level | Human Necessities | 9 | Expired |
| US9186320B2 | Controlled release delivery system for nasal application of neurotransmitters | Human Necessities | 8 | Active |
| US9238072B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 7 | Active |
| US9579280B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 6 | Active |
| US9962394B2 | Controlled release delivery system for nasal applications and method of treatment | Human Necessities | 4 | Active |
| US9801834B2 | Controlled release delivery system for nasal application of neurotransmitters | Human Necessities | 3 | Active |
| US5622704A | Anxiolytic | Human Necessities | 2 | Expired |
| US10596181B2 | Treatment of demyelinating diseases | Human Necessities | 2 | Active |
| US10898495B2 | Treatment of demyelinating diseases | Human Necessities | 1 | Active |
| US7767228B2 | Pharmaceutical composition for oral application and method for preparing thereof | Human Necessities | 0 | Active |
| US10729646B2 | Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutants | Emerging Cross-Sectional Technologies | 0 | Active |
| US11723911B2 | Treatment of demyelinating diseases | Human Necessities | 0 | Active |
| US11903951B2 | Nasal pharmaceutical compositions with a porous excipient | Human Necessities | 0 | Active |
| US9758264B2 | Filling and closing device, and method for filling and closing an applicator for active substances | Human Necessities | 0 | Active |
| US5591732A | Medicament for influencing the degree of activation of the central nervous system | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.